<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph" /><meta name="keywords" content="Leflunomide; Leflunomide; Arava; Leflunomide" /><meta name="IX" content="Leflunomide; Arava; Leflunomide" /><meta name="IXM" content="Leflunomide" /><title>LEFLUNOMIDE: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="82653.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="82653.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=82653.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2077.htm">10 Musculoskeletal and joint diseases</a> &gt; <a href="5182.htm">10.1 Drugs used in rheumatic diseases and gout</a> &gt; <a href="5288.htm">10.1.3 Drugs that suppress the rheumatic disease process</a> &gt; <a href="5304.htm">Drugs affecting the immune response</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="17350.htm" title="Previous: CICLOSPORIN">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="213632.htm#_213632" title="Next: Leflunomide">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a300032.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Leflunomide</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Miscellaneous Therapeutic Agents 92:00 &gt; Disease-modifying Antirheumatic Drugs 92:36</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/10839-p.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Leflunomide</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: L &gt; Interactions of Leflunomide</p></div></li></ul><ul><li><h3>British National Formulary (3)</h3></li><li><a href="5304.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Drugs affecting the immune response</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.1 Drugs used in rheumatic diseases and gout &gt; 10.1.3 Drugs that suppress the rheumatic disease process</p></div></li><li><a href="213632.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Leflunomide</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.1 Drugs used in rheumatic diseases and gout &gt; 10.1.3 Drugs that suppress the rheumatic disease process &gt; Drugs affecting the immune response &gt; LEFLUNOMIDE</p></div></li><li><a href="82665.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Arava®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.1 Drugs used in rheumatic diseases and gout &gt; 10.1.3 Drugs that suppress the rheumatic disease process &gt; Drugs affecting the immune response &gt; LEFLUNOMIDE</p></div></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0928.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Leflunomide</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; L</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/10839-p.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Leflunomide</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Analgesics Anti-inflammatory Drugs and Antipyretics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/05432.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Leflunomide</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; L &gt; LE</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E4E3E0R0D833.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Leflunomide</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; L</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c212.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Leflunomide</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; L</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_82653">LEFLUNOMIDE</h1><?highlighter on?><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i891.htm" title="Go to appendix 1">Leflunomide</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">(specialist use only) moderate to severe
active rheumatoid arthritis; active psoriatic arthritis</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF"> impaired bone-marrow function including anaemia,
leucopenia or thrombocytopenia (avoid if significant and due to causes
other than rheumatoid arthritis); recent treatment with other hepatotoxic
or myelotoxic disease-modifying antirheumatic drugs; washout procedures
recommended for serious adverse effects or before switching to other
disease-modifying antirheumatic drugs (consult product literature
and see Washout Procedure, below); history of tuberculosis; exclude pregnancy before treatment; effective contraception <b>essential </b>during treatment and for at least 2 years after
treatment in women and at least 3 months after treatment in men (plasma
concentration monitoring required; waiting time before conception
may be reduced with washout procedure—consult product literature and
see Washout Procedure, below); monitor full blood count (including differential white
cell count and platelet count) before treatment and every 2 weeks
for 6 months then every 8 weeks; monitor
liver function—see Hepatotoxicity, below; monitor blood pressure; <b>interactions: </b>Appendix 1 (<span>leflunomide</span>)</p><div class="cAV"><h3>Hepatotoxicity</h3> <p class="cAX">Potentially life-threatening hepatotoxicity
reported usually in the first 6 months; monitor liver function before
treatment and every 2 weeks for first 6 months then every 8 weeks.
Discontinue treatment (and institute washout procedure—consult product
literature and see Washout Procedure below) or reduce dose according
to liver-function abnormality; if liver-function
abnormality persists after dose reduction, discontinue treatment and
institute washout procedure</p></div><div class="cAV"><h3>Washout procedure</h3> <p class="cAX">To aid drug elimination in case
of serious adverse effect, or before starting another disease-modifying
antirheumatic drug, or before conception (see also Pregnancy below),
stop treatment and give <i>either </i><span>colestyramine</span> 8 g 3 times daily for 11 days <i>or </i>activated charcoal
50 g 4 times daily for 11 days; the concentration of the active metabolite
after washout should be less than 20 micrograms/litre (measured on
2 occasions 14 days apart) in men or women before conception—consult
product literature. Procedure may be repeated as necessary</p></div></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">severe immunodeficiency; severe hypoproteinaemia; serious
infection</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">avoid—active metabolite may accumulate; see also Cautions
above</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">manufacturer advises avoid in moderate or severe impairment—no
information available</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">avoid—active metabolite teratogenic in <i>animal</i> studies; effective contraception essential during treatment and
for at least 2 years after treatment in women and at least 3 months
after treatment in men (see also Cautions above)</p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">present in milk in <i>animal</i> studies—manufacturer
advises avoid</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">diarrhoea, nausea, vomiting, anorexia, oral mucosal
disorders, abdominal pain; increased blood pressure; headache, dizziness,
asthenia, paraesthesia; leucopenia; tenosynovitis; alopecia, rash,
dry skin, pruritus; <i>less commonly</i> taste disturbance,
anxiety, hyperlipidaemia, hypokalaemia, hypophosphataemia, anaemia,
thrombocytopenia, and tendon rupture; <i>rarely</i> hepatitis,
jaundice (see Hepatotoxicity, above), interstitial lung disease, severe
infection, eosinophilia, and pancytopenia; <i>very rarely</i> pancreatitis, hepatic failure (see Hepatotoxicity, above), peripheral
neuropathy, vasculitis, progressive multifocal leucoencephalopathy,
Stevens-Johnson syndrome, and toxic epidermal necrolysis; hypouricaemia,
reduced sperm count, and renal failure also reported; <b>important:</b> discontinue treatment and institute washout procedure (see Washout
Procedure under Cautions) in case of serious side-effect</p></div><div class="cAF"><h2>Dose</h2> <p class="cR">Rheumatoid arthritis, <span class="cAK">adult</span> over 18 years, initially 100 mg once daily for 3 days, then 10–20 mg
once daily</p><p class="cR">Psoriatic arthritis, <span class="cAK">adult</span> over
18 years, initially 100 mg once daily for 3 days, then 20 mg once
daily</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="213632.htm#_213632" title="Leflunomide">Leflunomide</a></li><li><a href="82665.htm#_82665" title="Arava®">Arava®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="17350.htm">Previous: CICLOSPORIN</a> | <a class="top" href="82653.htm#">Top</a> | <a accesskey="]" href="213632.htm#_213632" title="Leflunomide">Next: Leflunomide</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>